Vikram Purohit, an analyst from Morgan Stanley, maintained the Hold rating on ACELYRIN, INC. (SLRN – Research Report). The associated price target was lowered to $5.00. Discover top-rated stocks from ...

Morgan Stanley lowered the firm’s price target on Acelyrin (SLRN) to $5 from $6 and keeps an Equal Weight rating on the shares. The firm is updating its model to remove uveitis estimates following the ...